Emil D. Kakkis, President & CEO: Ultragenyx Pharmaceutical RARE Sell · Filed 24/12/31

Trade details

Type: Insider sale
Amount: $495,231.21
Shares · price: 11,727 sh · $42.23 a share
Held after: 2,183,985 sh
Stock: Ultragenyx Pharmaceutical RARE
Person: Emil D. KakkisPresident & CEO
Trade date: 24/12/30
Filed: 24/12/31
Days to filing: 1 days

Sold 0.5% of holdings

Share of holding sold: 0.5%

Ultragenyx Pharmaceutical trades, last 26 weeks

What else happened in Ultragenyx Pharmaceutical around then

Filed or reported within 30 days of the trade day · 24/11/30~25/01/29

Emil D. Kakkis's recent trades

Emil D. KakkisPresident & CEO
SellUltragenyx Pharmaceutical
Sell
Ultragenyx Pharmaceutical
RARE
$1.2M
54,404 sh
$1.2M
Filed 03/03
Traded 03/02
Emil D. KakkisPresident & CEO
Sell10b5-1 planUltragenyx Pharmaceutical
Sell10b5-1 plan
Ultragenyx Pharmaceutical
RARE
$3.1M
73,434 sh
$3.1M
Filed 25/03/04
Traded 25/03/03
Emil D. KakkisPresident & CEO
Sell10b5-1 planUltragenyx Pharmaceutical
Sell10b5-1 plan
Ultragenyx Pharmaceutical
RARE
$1.1M
25,000 sh
$1.1M
Filed 25/03/04
Traded 25/02/28
Emil D. KakkisOfficer
Planned sale10b5-1 planUltragenyx Pharmaceutical
Planned sale10b5-1 plan
Ultragenyx Pharmaceutical
RARE
$1.1M
25,000 sh
$1.1M
Filed 25/02/28
Traded 25/02/28
Emil D. KakkisPresident & CEO
Sell10b5-1 planUltragenyx Pharmaceutical
Sell10b5-1 plan
Ultragenyx Pharmaceutical
RARE
$413.7K
8,273 sh
$413.7K
Filed 24/12/11
Traded 24/12/10